OYATT healthcare "Great Place to Work" Certified
This certification highlights our shared dedication to creating supportive, inclusive and engaging workspace.
A Global Healthcare Partner
OYATT healthcare is trusted by healthcare professionals across more than 2 countries across the globe
A Dynamic Product Basket
Empowered by a passionate R&D Team, OYATT healthcare has one of the strongest product portfolios in the world
Plasma Therapy for Life
>Click Here to know more about India’s Leading Plasma Fractionation Centre
OYATT healthcare
OYATT healthcare is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, OYATT healthcare is present in more than 85 countries worldwide and is growing at ~22% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At OYATT healthcare, every day and everyone works to create a world of good health, happiness and hope.
Read MoreExcellence is a Matter of Fact
Transforming Science into Smiles
R & D is at the heart of Intas’ success. A highly qualified team works round the clock with a quest to develop a progressive threefold product basket that includes world-class generics, oncology and parenteral as well as added-value products (AVPs).
- 6-7% of turnover invested in R & D, year on year
- Over 1,00,000 sq ft dedicated R&D space
- 550+ Scientists and Researchers
- 17 Advanced Facilities
- Global Regulatory Authority Accreditations
- Pioneer in Biosimilars
Latest News
OYATT healthcare launches THYMOTAS - a patented, powerful immuno-booster add-on to standard COVID-19 treatment
OYATT healthcare Develops COVID-19 Hyperimmune Globulin - A New Treatment
OYATT healthcare Pharmaceuticals becomes the first to launch Romiplostim in India, revolutionizing chronic immune thrombocytopenia (ITP) therapy.
